Company profile

Ticker
FOMX
Exchange
Website
CEO
David Domzalski
Employees
Incorporated in
Location
Fiscal year end
Former names
Foamix Ltd.
SEC CIK

FOMX stock data

(
)

Calendar

12 Mar 20
1 Jun 20
31 Dec 20

News

Company financial data Financial data

Quarter (USD) Dec 19 Sep 19 Jun 19 Mar 19
Revenue 135K 0 0 308K
Net income -37.82M -23.16M -18.99M -15.2M
Diluted EPS 0.63 0.41 0.35 0.28
Net profit margin -28015% -4936%
Operating income -37.43M -23.2M -19.36M -15.88M
Net change in cash 3.23M 1.45M 20.09M -8.87M
Cash on hand 43.76M 40.53M 39.09M 18.99M
Cost of revenue
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue 443K 3.6M 3.67M 5.53M
Net income -95.18M -74.16M -65.72M -29.34M
Diluted EPS 1.66 1.7 1.76 0.91
Net profit margin -21485% -2063% -1791% -531%
Operating income -95.87M -74.89M -65.61M -29.65M
Net change in cash 15.89M 11.91M -15.23M 12.4M
Cash on hand 43.76M 27.87M 15.96M 31.19M
Cost of revenue 13K 59K

Financial data from company earnings reports

Date Owner Security Transaction Code $Price #Shares $Value #Remaining
9 Mar 20 Aharon Schwartz Options Ordinary Shares Sale back to company Dispose D 2.66 49,412 131.44K 0
9 Mar 20 Matthew T. Wiley Ordinary Shares Sale back to company Dispose D 0 78,799 0 0
9 Mar 20 Matthew T. Wiley Options Ordinary Shares Sale back to company Dispose D 4.03 96,365 388.35K 0
9 Mar 20 Matthew T. Wiley Options Ordinary Shares Sale back to company Dispose D 4.06 100,000 406K 0
9 Mar 20 Stuart Iain Ordinary Shares Sale back to company Dispose D 0 91,303 0 0
9 Mar 20 Stuart Iain Ordinary Shares Sale back to company Dispose D 0 12,333 0 91,303
9 Mar 20 Stuart Iain Options Ordinary Shares Sale back to company Dispose D 4.03 96,365 388.35K 0
9 Mar 20 Stuart Iain Options Ordinary Shares Sale back to company Dispose D 3.77 75,997 286.51K 0
9 Mar 20 Stuart Iain Options Ordinary Shares Sale back to company Dispose D 6.35 30,000 190.5K 0
9 Mar 20 Stuart Iain Options Ordinary Shares Sale back to company Dispose D 5.39 13,000 70.07K 0
46.9% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 66 60 +10.0%
Opened positions 17 10 +70.0%
Closed positions 11 11
Increased positions 18 22 -18.2%
Reduced positions 17 12 +41.7%
13F shares
Current Prev Q Change
Total value 299.85M 87.86M +241.3%
Total shares 28.61M 28.91M -1.0%
Total puts 87.3K 19.63K +344.8%
Total calls 99.5K 148.26K -32.9%
Total put/call ratio 0.9 0.1 +562.8%
Largest owners
Shares Value Change
Perceptive Advisors 11.2M $37.31M 0.0%
DSC Advisors 3.37M $11.21M +9.9%
Orbimed Advisors 2.58M $8.59M -46.2%
Mangrove Partners 1.78M $5.93M NEW
MS^L Morgan Stanley 1.41M $4.69M +90618.3%
AXAHY Axa 1.3M $4.34M 0.0%
Sofinnova Investments 1.16M $3.87M -3.1%
Parkman Healthcare Partners 932.14K $3.1M NEW
BLK BlackRock 564K $1.88M -5.6%
Senvest Management 506.21K $1.69M -33.0%
Largest transactions
Shares Bought/sold Change
Orbimed Advisors 2.58M -2.21M -46.2%
Mangrove Partners 1.78M +1.78M NEW
MS^L Morgan Stanley 1.41M +1.41M +90618.3%
Parkman Healthcare Partners 932.14K +932.14K NEW
Sio Capital Management 0 -920.8K EXIT
DLD Asset Management 0 -525K EXIT
Baker Bros. Advisors 0 -498.19K EXIT
683 Capital Management 375.1K +375.1K NEW
Millennium Management 0 -345.1K EXIT
DAFNA Capital Management 0 -305.5K EXIT

Financial report summary

?
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg

Patents

GRANT
Utility
Topical tetracycline compositions
7 Apr 20
Inventors: Dov Tamarkin, Elana Gazal, Irakliy Papiashvili, Yohan Hazot, David Schuz, Rita Keynan
APP
Utility
Cosmetic and Pharmaceutical Foam
2 Apr 20
The invention relates to an alcohol-free cosmetic or pharmaceutical foam carrier comprising water, a hydrophobic solvent, a foam adjuvant agent, a surface-active agent and a water gelling agent.
GRANT
Utility
Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
17 Mar 20
The present invention teaches a foamable pharmaceutical and cosmetic compositions comprising an aprotic polar solvent; foam compositions and uses thereof.
APP
Utility
Dicarboxylic Acid Foamable Vehicle and Pharmaceutical Compositions Thereof
12 Mar 20
The present invention teaches a foamable pharmaceutical carrier comprising a benefit agent, selected from the group consisting of a dicarboxylic acid and a dicarboxylic acid ester; a stabilizer selected from the group consisting of at least one surface-active agent; at least one polymeric agent and mixtures thereof; a solvent selected from the group consisting of water, a hydrophilic solvent, a hydrophobic solvent, a potent solvent, a polar solvent, a silicone, an emollient, and mixtures thereof, wherein the benefit agent, stabilizer and solvent are selected to provide a composition that is substantially resistant to aging and to phase separation and or can substantially stabilize other active ingredients.
APP
Utility
Wax Foamable Vehicle and Pharmaceutical Compositions Thereof
6 Feb 20
Unique foamable vehicles or carriers comprising at least one wax, waxy substance, counterpart or derivative, a stabilizer, water, and a propellant are provided.